Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04057352 · ClinicalTrials.gov registry record · NA
Citadel Embolization Device Study
A NA study of Unruptured Wide-neck Aneurysms, sponsored by Stryker Neurovascular.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 20
- Study locations
NCT04057352 is a NA study of Unruptured Wide-neck Aneurysms that is active but no longer recruiting, run by Stryker Neurovascular. The registered enrollment target is 150 participants. The trial reports 20 study locations across 12 states.
The verdict
NCT04057352, a NA study of Unruptured Wide-neck Aneurysms, is active but no longer recruiting, sponsored by Stryker Neurovascular.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to gather safety and effectiveness data on Stryker Neurovascular's Next Generation Target Detachable Coil (hereafter referred to as the Citadel Embolization Device), when used with Target Detachable Coils, in the treatment of wide-neck intracranial aneurysms.
Conditions Studied
Interventions
- DEVICE Citadel Embolization Device
Study Locations (20)
California
- Cedars-Sinai Medical Center - Los Angeles
- California Pacific Medical Center - San Francisco
- UCSF Medical Center - San Francisco
- John Muir Health - Walnut Creek
Florida
- University of Florida - Gainesville
- Baptist Health - Jacksonville
- University of Miami/Jackson Memorial - Miami
- Tampa General Hospital - Tampa
Kentucky
- Baptist Health - Lexington
- University of Kentucky - Lexington
Michigan
- McLaren Health Center - Flint
- Spectrum Health - Grand Rapids
Arizona
- Carondelet St. Joseph Hospital - Tucson
Colorado
- RIA Neurovascular - Englewood
Illinois
- Northwestern University - Chicago
Indiana
- Indiana Methodist - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-07-18 |
| Est. Completion | 2026-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04057352
The ClinicalTrials.gov registry entry for NCT04057352 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stryker Neurovascular, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Unruptured Wide-neck Aneurysms appearing as the primary indexed condition, and to 1 intervention - of which Citadel Embolization Device is the first listed.
NCT04057352 reports 20 study locations spanning 12 distinct geographic areas - top geographies include California, Florida, Kentucky.
Frequently Asked Questions
What is clinical trial NCT04057352 about?
NCT04057352 is a clinical study titled "Citadel Embolization Device Study". The purpose of this study is to gather safety and effectiveness data on Stryker Neurovascular's Next Generation Target Detachable Coil (hereafter referred to as the Citadel Embolization Device), when used with Target Detachable Coils, in the treatment of wide-neck intracranial aneurysms.
What is the current status of trial NCT04057352?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2019-07-18. Estimated completion is 2026-11-15.
What conditions does trial NCT04057352 study?
This clinical trial studies the following conditions: Unruptured Wide-neck Aneurysms.
What interventions are being tested in trial NCT04057352?
The interventions under investigation include: Citadel Embolization Device (DEVICE).
Who is sponsoring clinical trial NCT04057352?
This trial is sponsored by Stryker Neurovascular, which has 13 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04057352 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.